Ventricular arrhythmias in a pregnant female – clinical implications

Ewelina Nowak; Marianna Janion; Agnieszka Wencel-Wawrzeńczyk; Marek Sikorski; Izabela Wojarska

doi:10.5114/ms.2017.68708

eISSN: 2300-6722
ISSN: 1899-1874

Medical Studies/Studia Medyczne

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2017
vol. 33

Send email

Copy url:

abstract:

Case report

Ventricular arrhythmias in a pregnant female – clinical implications

Ewelina Nowak

¹

,

Marianna Janion

^{1, 2}

,

Agnieszka Wencel-Wawrzeńczyk

³

,

Marek Sikorski

⁴

,

Izabela Wojarska

⁵

Department of Internal Diseases, Cardiology and Medicine Nursing, Institute of Nursing and Midwifery, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
2nd Department of Cardiology, Świętokrzyskie Cardiology Centre, Regional Hospital, Kielce, Poland
Department of Midwifery, Gynecology and Midwifery-Gynecological Nursing, Institute of Nursing and Midwifery, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
Department of Perinatology and Gynecological – Midwifery Nursing, Institute of Nursing and Midwifery, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
Doctoral Studies, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland

Medical Studies/Studia Medyczne 2017; 33 (2): 133–136

DOI: https://doi.org/10.5114/ms.2017.68708

Online publish date: 2017/06/30

View full text Get citation

PlumX metrics:

Physiological changes occurring during pregnancy, at the time of childbirth, and in the postpartum period may influence the occurrence, and increase in intensity of, heart rhythm abnormalities. There is insufficient data on the safety and effectiveness of pharmacological treatment in the group of pregnant women. Cardiac arrhythmia induced by pregnancy rarely requires introduction of pharmaceuticals. It should be noted that most antiarrhythmic agents are not recommended for use during pregnancy and the breastfeeding period. In cases where a drug use is necessary, the most popular choice is -blockers or a calcium channel blocker – verapamil, which does not have teratogenic effects, but does get transferred to the mothers’ milk. The presented case study concerns a woman with no structural heart defects in her third pregnancy, with very ill-tolerated ventricular arrhythmia.

keywords:

Ventricular arrhythmias in a pregnant female – clinical implications

Ewelina Nowak 1 , Marianna Janion 1, 2 , Agnieszka Wencel-Wawrzeńczyk 3 , Marek Sikorski 4 , Izabela Wojarska 5

pregnancy, pharmacotherapy, ventricular arrythmias

Ewelina Nowak

¹

,

Marianna Janion

^{1, 2}

,

Agnieszka Wencel-Wawrzeńczyk

³

,

Marek Sikorski

⁴

,

Izabela Wojarska

⁵